Outcomes of Autologous Stem Cell Transplantation in Elderly Patients With Multiple Myeloma
Phyllis McKiernan, a nurse practitioner at John Theurer Cancer Center, Hackensack Medical Center, discusses a study of outcomes of autologous stem cell transplantation in very elderly patients with multiple myeloma.
Phyllis McKiernan, a nurse practitioner at John Theurer Cancer Center, Hackensack Medical Center, discusses a study of outcomes of autologous stem cell transplantation in very elderly patients with multiple myeloma.
This study looked at 496 patients who underwent autologous stem cell transplantation for multiple myeloma over a 10-year period. Of the 496 patients, 24 patients were over the age of 75.
McKiernan notes that elderly patients are typically considered to be those who are over the age of 65, however, many patients undergo transplantation at an even older age. Thus, investigators wanted to follow the patients who were over the age of 75 to determine what influenced the course of their transplantation and their outcomes.
